These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 15148229)

  • 21. Selective photodynamic therapy by targeted verteporfin delivery to experimental choroidal neovascularization mediated by a homing peptide to vascular endothelial growth factor receptor-2.
    Renno RZ; Terada Y; Haddadin MJ; Michaud NA; Gragoudas ES; Miller JW
    Arch Ophthalmol; 2004 Jul; 122(7):1002-11. PubMed ID: 15249365
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Photodynamic therapy with verteporfirin in corneal neovascularization].
    Verdiguel-Sotelo K; Hernández-López A; González-Camarena PI; Devereux-García R; Pineda-Espinosa MS; Gómez-Dávila R
    Rev Med Inst Mex Seguro Soc; 2010; 48(3):313-6. PubMed ID: 21192905
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Triple therapy for corneal neovascularization: a case report.
    Veritti D; Vergallo S; Lanzetta P
    Eur J Ophthalmol; 2012; 22 Suppl 7():S126-8. PubMed ID: 21928258
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Photodynamic therapy for corneal neovascularization using topically administered ATX-S10 (Na).
    Gohto Y; Obana A; Kanai M; Nagata S; Miki T; Nakajima S
    Ophthalmic Surg Lasers; 2000; 31(1):55-60. PubMed ID: 10976562
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Successful photodynamic therapy for subretinal neovascularisation due to Sorsby's fundus dystrophy: 1 year follow up.
    Wong SC; Fong KC; Lee N; Gregory-Evans K; Gregory-Evans CY
    Br J Ophthalmol; 2003 Jun; 87(6):796-7. PubMed ID: 12770993
    [No Abstract]   [Full Text] [Related]  

  • 26. Corneal neovascularization in rats as a model for photothrombotic therapy using bacteriochlorin a and an argon laser.
    van Gool CA; Schuitmaker HJ; Jager MJ
    Graefes Arch Clin Exp Ophthalmol; 1995 Jul; 233(7):435-40. PubMed ID: 7557509
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of reduced and standard light application in photodynamic therapy of the eye in two rabbit models.
    Framme C; Flucke B; Birngruber R
    Graefes Arch Clin Exp Ophthalmol; 2006 Jul; 244(7):773-81. PubMed ID: 16440207
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Photodynamic effect of a new photosensitizer ATX-S10 on corneal neovascularization.
    Gohto Y; Obana A; Kaneda K; Miki T
    Exp Eye Res; 1998 Sep; 67(3):313-22. PubMed ID: 9778412
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Photodynamic therapy with verteporfin for juxtafoveal choroidal neovascularisation secondary to pathological myopia.
    Gibson J
    Eye (Lond); 2005 Aug; 19(8):829-30. PubMed ID: 16086038
    [No Abstract]   [Full Text] [Related]  

  • 30. [Research status of photodynamic therapy for corneal neovascularization].
    Wang HY; Wei RH; Zhao SZ
    Zhonghua Yan Ke Za Zhi; 2012 Jul; 48(7):662-5. PubMed ID: 22943874
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Intravitreal ranibizumab in combination with verteporfin photodynamic therapy in neovascular macular degeneration].
    Soucek P; Soucková I
    Cesk Slov Oftalmol; 2008 Jul; 64(4):135-40. PubMed ID: 18780651
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Verteporfin photodynamic therapy involving the optic nerve for peripapillary choroidal neovascularization.
    Bernstein PS; Horn RS
    Retina; 2008 Jan; 28(1):81-4. PubMed ID: 18185142
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Simultaneous but not prior inhibition of VEGF165 enhances the efficacy of photodynamic therapy in multiple models of ocular neovascularization.
    Ju M; Mailhos C; Bradley J; Dowie T; Ganley M; Cook G; Calias P; Lange N; Adamis AP; Shima DT; Robinson GS
    Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):662-70. PubMed ID: 18235012
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Photodynamic therapy for central serous chorioretinopathy using a reduced dose of verteporfin.
    Williams MA; Mulholland C; Silvestri G
    Can J Ophthalmol; 2008 Feb; 43(1):123. PubMed ID: 18219357
    [No Abstract]   [Full Text] [Related]  

  • 35. Half-dosage and bolus injection photodynamic therapy for symptomatic circumscribed choroidal hemangioma: a case report.
    Hu Y; Chen Y; Chen L
    Photodiagnosis Photodyn Ther; 2015 Sep; 12(3):526-9. PubMed ID: 26007239
    [No Abstract]   [Full Text] [Related]  

  • 36. Spotlight on verteporfin in subfoveal choroidal neovascularisation.
    Keam SJ; Scott LJ; Curran MP
    Drugs Aging; 2004; 21(3):203-9. PubMed ID: 14979737
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vascular endothelial growth factor in a recipient cornea acts as a prognostic factor for corneal graft reaction development.
    Sekelj S; Dekaris I; Balog T; Mahovne I; Krstonijevic EK; Janjetovic Z; Arar ZV; Aric I
    Curr Eye Res; 2015 Apr; 40(4):407-14. PubMed ID: 24912114
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinicopathological findings of choroidal neovascularisation following verteporfin photodynamic therapy.
    Gelisken F; Lafaut BA; Inhoffen W; Voelker M; Grisanti S; Bartz-Schmidt KU
    Br J Ophthalmol; 2004 Feb; 88(2):207-11. PubMed ID: 14736776
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Photodynamic therapy with verteporfin combined with intravitreal injection of bevacizumab for occult and classic CNV in AMD].
    Maier M; Haas K; Feucht N; Fiore B; Winkler von Mohrenfels C; Clos A; Lohmann C
    Klin Monbl Augenheilkd; 2008 Jul; 225(7):653-9. PubMed ID: 18642209
    [TBL] [Abstract][Full Text] [Related]  

  • 40. COMPARISON OF HALVING THE IRRADIATION TIME OR THE VERTEPORFIN DOSE IN PHOTODYNAMIC THERAPY FOR CHRONIC CENTRAL SEROUS CHORIORETINOPATHY.
    Shiode Y; Morizane Y; Kimura S; Hosokawa M; Kawata T; Doi S; Hosogi M; Fujiwara A; Shiraga F
    Retina; 2015 Dec; 35(12):2498-504. PubMed ID: 26035398
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.